Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by ECSINVESTORon Mar 30, 2021 8:24pm
104 Views
Post# 32911378

RE:RE:RE:AGM

RE:RE:RE:AGMAch. My bad - I keep forgettinmg their year end is Sept 30th... Should be good results based on the continuing organic growth. Wouldn't mind a shoy in the arm from a Plexuss deal. 

I only listened to bits and pieces but did they back track from the 400 000 units per week by year end (in their original projections) to 150 000 units per week for VTM? I look at Ontario and they are testing at a rate of 50000+/day. Should be able to suck up whatever Microbix can throw at them....
<< Previous
Bullboard Posts
Next >>